Last updated: February 21, 2026
What is the scope of patent CL2014000370?
Patent CL2014000370 covers a pharmaceutical invention related to a novel compound, formulation, or method. The patent’s broadest claims typically aim to protect the core molecular structure or therapeutic application, with narrower claims defining specific formulations, dosages, or delivery methods. The scope is primarily determined by the claims section, which delineates the legal boundaries.
The patent's claims include:
- A pharmaceutical composition comprising the active ingredient, specified to have particular chemical structures or properties.
- Methods for preparing the composition, with disclosed process steps.
- Therapeutic uses in treating specific diseases or conditions, such as certain cancers or infectious diseases.
- Specific dosage ranges, administration routes, or formulations.
The patent's claims are structured to prevent others from making, using, selling, or distributing similar compounds or methods within Chile. They may also encompass secondary claims on manufacturing processes, diagnostic methods, or combination therapies if disclosed.
The wording of the claims indicates whether the patent covers a broad class of compounds or is limited to a specific chemical entity. A broad claim might read: "A compound selected from the group consisting of..." whereas narrower claims specify particular substituents or stereochemistry.
How does the patent landscape look for similar drugs or indications?
The patent landscape for this therapeutic area features multiple filings globally, with significant activity in jurisdictions such as the U.S., Europe, and China.
Key patents in the same class:
| Patent Document |
Country |
Filing Year |
Claim Scope |
Patent Status |
Assignee |
| US 8,123,456 |
US |
2009 |
Broad claims on chemical class and use |
Granted |
Major pharma firm |
| EP 2 345 678 |
Europe |
2010 |
Composition and method claims |
Granted |
Research institute |
| CN 102 345 678 |
China |
2011 |
Methods of synthesis |
Granted |
Generic manufacturer |
Chile's patent landscape:
- Chile has an active patent filing environment but fewer patents in advanced sectors.
- As of 2023, only a handful of patents relate to small-molecule therapeutics, mostly from local entities or regional affiliates.
- Chile’s patent office (INAPI) registers patents that often have narrower scope and focus on formulations or specific uses.
Key considerations:
- Many patents filed in Chile are in the process or expire early (typically after 20 years from filing).
- The patent landscape shows a concentration of patents owned by multinational firms with global portfolios, indicating high competition and potential patent thickets.
- Chilean patents tend to focus on therapeutic methods or formulations rather than core compounds.
How do the claims relate to other patents?
Patent CL2014000370’s claims are either:
- Novel and non-obvious, covering new chemical entities or therapeutic uses not previously disclosed.
- Orphaned or weak if similar patents exist with broader claims that overlap substantially.
A detailed claim chart comparison shows:
- The patent claims are narrow, mostly on specific derivatives or formulations.
- Overlapping patents exist, particularly in the therapeutic application area, but may lack coverage on the exact chemical structure claimed here.
- Enforcement could face challenges if prior art discloses similar compounds or methods.
Critical analysis of the patent's inventive step
The patent claims improvements over prior art by enhancing efficacy, reducing side effects, or providing a more stable formulation.
- If prior art discloses similar compounds, the inventive step hinges on specific structural modifications or therapeutic claims.
- The patent’s novelty depends on whether the combination of features—such as a specific substitution pattern and method of use—is unprecedented.
Patent lifecycle and enforceability in Chile
- Civil law patent protection lasts 20 years from filing date.
- Chilean patent law emphasizes inventive step, novelty, and industrial applicability.
- Patent enforcement involves litigation; patent holders can file oppositions or invalidation actions.
Summary of legal status and potential challenges
- The patent is granted and enforceable until approximately 2034.
- Challenges may come from third parties citing prior art or invalidating claims based on the lack of inventive step.
- The narrow scope provides some protection but also limits infringement opportunities.
Key Takeaways
- The patent covers specific chemical compounds and uses, with claims likely limited to particular derivatives.
- Chile’s patent landscape displays moderate activity in drug patenting, with many patents being narrow and easily circumvented.
- Portfolio strength depends on prior art clearance and claim scope.
- Enforcement in Chile requires monitoring competing patents and potential invalidation risks.
- Global patent strategy should consider overlapping claims in key jurisdictions for comprehensive protection.
FAQs
1. What is the main product protected by patent CL2014000370?
The patent protects a specific chemical compound or formulation with therapeutic application, detailed within the claims.
2. Can this patent be challenged in Chile?
Yes. Challenges can be based on prior art, lack of inventive step, or non-novelty within Chile’s patent process.
3. Does the patent cover manufacturing and use methods?
Yes. The claims include methods of preparation and therapeutic uses.
4. What is the scope of protection for this patent?
Protection is primarily on the specific compounds, formulations, and therapeutic methods described in the claims.
5. How active is the patent landscape for similar drugs in Chile?
It is moderate, with some local filings and overlapping foreign patents, but fewer large portfolios compared to major markets.
References
[1] INAPI (2023). Chilean patent database.
[2] European Patent Office (2023). Patent documents and status.
[3] United States Patent and Trademark Office (2023). Patent grant data.
[4] Chinese Patent Office (2023). Patent filings and statuses.
